CClinicalTrials.gg
CompletedNCT03645590Updated May 1, 2026Results posted

Stroke Ready - Optimizing Acute Stroke Care

An interventional study of Stroke Ready in Stroke, Acute and Stroke, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by University of Michigan · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
5,970
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The study aims to increase acute stroke treatment rates in Flint, Michigan through a two-pronged approach of hospital and community level interventions. It also aims to inform future stroke preparedness interventions by exploring the relative importance of hospital optimization and community interventions.

Read the detailed description

In this study, the participants who received the intervention are a separate group from those analyzed in the outcome measures. Stroke Ready was a multilevel intervention that included a hospital based emergency department optimization component conducted from October 2017 through May 2018 and a community based stroke preparedness intervention conducted from June 2018 through March 2020. The emergency department component focused on improving hospital level acute stroke care processes and did not involve participant enrollment, individual level data collection, or participant level outcomes. Stroke education sessions were offered to community members in quadrant based groups between 2017 and 2020, but this was simply for administrative purposes, not for analytical distinctions among the groups. Demographic information was collected based on workshop educators' perceptions of those in attendance and not taken at the individual level.

Outcome measures about acute stroke treatment rates were collected Flint wide for two different time periods: a preintervention period from July 2010 to September 2017 and a postintervention period from October 2017 to March 2020. The postintervention period was defined based on the initiation of the Stroke Ready intervention in October 2017, corresponding to the start of the emergency department optimization component.

Outcome measure data was not directly related to the intervention, as the intervention was performed among community members and outcomes obtained in people who had a stroke or TIA within time periods before and after the intervention. The workshop data was collected without identifiers at the group level based on perceptions of stroke educators. Baseline data for stroke patients was acquired from the medical record.

Consequently, the information in the Participant Flow and Adverse Events modules only reflects those who attended the community workshops in person or remotely and has no relation to the population addressed in the outcome measures.

02

Conditions studied

  • Stroke, Acute
  • Stroke

Browse trials for

03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 5,970 is above the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion criteria:Adult stroke patients who presented to one of three hospitals in the Flint community.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5,970 participants (actual)

Study arms

  • Experimental
    Stroke Ready Community intervention

    We divided the Flint community into four quadrants. We will focus our workshops and posters on one quadrant, but not exclusively, moving quadrants every 6 months over the course of two years.

    Behavioral: Stroke Ready

Interventions

  • BehavioralStroke Ready

    Stroke Ready community intervention consists of peer facilitated educational workshops, stroke music video, and mass media campaign including print materials (e.g. posters, brochure), health promotion mailers, radio/Television public health service announcements, and the Stroke Ready website and Facebook page.

06

What researchers measure

Primary outcomes

  1. Utilization of Thrombolysis Among Ischemic Stroke and Transient Ischemic Attack (TIA) Patients

    Proportion of Tissue Plasminogen Activator (tPA) treatment utilization among ischemic stroke and TIA patients in pre vs. post intervention periods in all Genesee county hospitals. This is a distinct group of county-wide patients who may or may not include any individuals who received the workshop intervention.

    Time frame: Data for this outcome was from county-wide medical records from July 2010 through September 2017 (pre-intervention) and from October 2017 through March 2020 (post-intervention, defined by initiation of the emergency department optimization component).

Secondary outcomes

  1. Percent of Stroke and TIA Patients Who Arrive to the Emergency Department by Ambulance

    Stroke and TIA patient arrival by EMS in Pre vs. Post Intervention periods

    Time frame: Data was gathered retrospectively from the medical record for Flint stroke or TIA patients from October 2017 through March 2020, following initiation of the Stroke Ready intervention.

07

Results

Posted May 1, 2026

Participant flow

All four quadrants received the same workshops. Participants were individuals attending workshops. Outcome measures used de-identified, city-wide stroke and TIA patient data from pre- and post-intervention periods under an IRB-approved waiver of consent; these patients were not enrolled. Peer leaders were not enrolled. The intervention also included a hospital-based emergency department optimization component beginning October 2017 that did not involve participant enrollment.

Quad 1 intervention 6/1/2018-11/30/2018
Participant flow — Quad 1 intervention 6/1/2018-11/30/2018
MilestoneStroke Ready Community Intervention Quadrant 1Stroke Ready Community Intervention Quadrant 2Stroke Ready Community Intervention Quadrant 3Stroke Ready Community Intervention Quadrant 4
Started1509000
Completed1509000
Not completed0000
Quad. 2 intervention 12/1/2018-5/31/2019
Participant flow — Quad. 2 intervention 12/1/2018-5/31/2019
MilestoneStroke Ready Community Intervention Quadrant 1Stroke Ready Community Intervention Quadrant 2Stroke Ready Community Intervention Quadrant 3Stroke Ready Community Intervention Quadrant 4
Started0152600
Completed0152600
Not completed0000
Quad.3 intervention 6/1/2019-11/30/2019
Participant flow — Quad.3 intervention 6/1/2019-11/30/2019
MilestoneStroke Ready Community Intervention Quadrant 1Stroke Ready Community Intervention Quadrant 2Stroke Ready Community Intervention Quadrant 3Stroke Ready Community Intervention Quadrant 4
Started0023290
Completed0023290
Not completed0000
Quad.4 intervention 12/1/2019-8/31/2020
Participant flow — Quad.4 intervention 12/1/2019-8/31/2020
MilestoneStroke Ready Community Intervention Quadrant 1Stroke Ready Community Intervention Quadrant 2Stroke Ready Community Intervention Quadrant 3Stroke Ready Community Intervention Quadrant 4
Started000606
Completed000606
Not completed0000

Outcome measures

PrimaryUtilization of Thrombolysis Among Ischemic Stroke and Transient Ischemic Attack (TIA) Patients

Proportion of Tissue Plasminogen Activator (tPA) treatment utilization among ischemic stroke and TIA patients in pre vs. post intervention periods in all Genesee county hospitals. This is a distinct group of county-wide patients who may or may not include any individuals who received the workshop intervention.

Time frame:
Data for this outcome was from county-wide medical records from July 2010 through September 2017 (pre-intervention) and from October 2017 through March 2020 (post-intervention, defined by initiation of the emergency department optimization component).
Reported as:
Number · Percent of stroke and TIA patients
Utilization of Thrombolysis Among Ischemic Stroke and Transient Ischemic Attack (TIA) Patients
Percent of stroke and TIA patientsFlint Stroke and TIA Patients Before Initiation of Stroke Ready InterventionFlint Stroke and TIA Patients After Initiation of Stroke Ready Intervention
Utilization of Thrombolysis Among Ischemic Stroke and Transient Ischemic Attack (TIA) Patients414
Statistical analysis
  • Flint Stroke and TIA Patients Before Initiation of Stroke Ready Intervention vs Flint Stroke and TIA Patients After Initiation of Stroke Ready Intervention · Odds ratio (or): 1.13 · 95% CI 0.74 to 1.70
SecondaryPercent of Stroke and TIA Patients Who Arrive to the Emergency Department by Ambulance

Stroke and TIA patient arrival by EMS in Pre vs. Post Intervention periods

Time frame:
Data was gathered retrospectively from the medical record for Flint stroke or TIA patients from October 2017 through March 2020, following initiation of the Stroke Ready intervention.
Reported as:
Number · Percent of stroke and TIA patients
Percent of Stroke and TIA Patients Who Arrive to the Emergency Department by Ambulance
Percent of stroke and TIA patientsFlint Stroke and TIA Patients Before Initiation of Stroke Ready InterventionFlint Stroke and TIA Patients After Initiation of Stroke Ready Intervention
Percent of Stroke and TIA Patients Who Arrive to the Emergency Department by Ambulance4958
Statistical analysis
  • Flint Stroke and TIA Patients Before Initiation of Stroke Ready Intervention vs Flint Stroke and TIA Patients After Initiation of Stroke Ready Intervention · Odds ratio (or): 1.0 · 95% CI 0.99 to 1.02
Post-hocAge of Patients With Stroke or TIA From Retrospective Data Pull for the Genesee County Hospitals

Retrospective data pulls were done with IRB permission to compare types of care before and after any stroke ready intervention in the city had begun. This is the mean age of those patients. Note this population is distinct from "participants" in the workshops.

Time frame:
Data for this outcome was from county-wide medical records from July 2010 through September 2017 (pre-intervention) and from October 2017 through March 2020 (post-intervention, defined by initiation of the emergency department optimization component).
Reported as:
Mean · years
Age of Patients With Stroke or TIA From Retrospective Data Pull for the Genesee County Hospitals
yearsStroke and TIA Patients in Flint Pre-intervention 7/2010-9/2017Stroke and TIA Patients in Flint Post-intervention 10/2017-3/2020
Age of Patients With Stroke or TIA From Retrospective Data Pull for the Genesee County Hospitals68.0 ± 14.267.4 ± 14.02
Post-hocSex of Flint Stroke and TIA Patients

The data source to identify sex was the electronic medical record and administrative data from all Genesee County hospitals.

Time frame:
Retrospective data collected, Data for this outcome measure was gathered from county-wide medical records from July 2010 through September 2017, and from October 2017 through March 2020.
Reported as:
Number · patients (not participants in workshops)
Sex of Flint Stroke and TIA Patients
patients (not participants in workshops)Stroke and TIA Patients in Flint Pre-intervention 7/2010-9/2017Stroke and TIA Patients in Flint Post-intervention 10/2017-3/2020
Female1289559
Male1016463
Post-hocCustomized Race/Ethnicity of Flint Patients Who Presented With Stroke or TIA Pre- and Post- Intervention

Retrospective data analysis of Genesee county stroke and TIA patients' race

Time frame:
From July 2010 through September 2017, and from October 2017 through March 2020.
Reported as:
Number · patients (not participants in workshops)
Customized Race/Ethnicity of Flint Patients Who Presented With Stroke or TIA Pre- and Post- Intervention
patients (not participants in workshops)Stroke and TIA Patients in Flint Pre-intervention 7/2010-9/2017Stroke and TIA Patients in Flint Post-intervention 10/2017-3/2020
Black1233514
Other race and ethnicity1072508

Adverse events

Collected over For this study, the Flint community was divided into four administrative quadrants. The workshops, mailers, and social media focused on one quadrant at a time, progressing quadrants every 6 months over the course of two years. Adverse events were not monitoring Stroke or TIA patients as they were neither intervention workshop participants nor considered enrolled.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Stroke Ready Community Intervention0/5,970 (0%)0/5,970 (0%)0/5,970 (0%)

Baseline characteristics

Workshop attendee demographic information was based on peer educators' perceptions of attendees, not taken at the individual or recorded at the quadrant level. 264 workshop participants received virtual intervention, from whom no demographic data other than US location was collected. Workshop participants are a separate population from the stroke and TIA patients. Outcome measure data was not directly related to the intervention. As quadrants have no age, sex or race, they couldn't be analyzed.

Age, Customized
Age, Customized(Participants)Stroke Ready Community Intervention Workshop Attendees
Participants perceived by workshop educators to be 18-40916
Participants perceived by workshop educators to be 41-643312
Participants perceived by workshop educators to be 65 and over1478
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Stroke Ready Community Intervention Workshop Attendees
Attendees at workshops where group was perceived by educators to be mostly female1522
Attendees at workshops where group was perceived by educators to be mostly male128
Attendees at workshops where group was perceived by educators to be approximately evenly male/female4056
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Stroke Ready Community Intervention Workshop Attendees
Attendees at workshops where group was perceived by educators to be mostly Black2066
Attendees at workshops where group was perceived by educators to be mostly White1020
Attendees at workshops where group was perceived by educators to be approximately evenly Black/White2620
Region of Enrollment
Region of Enrollment(Participants)Stroke Ready Community Intervention Workshop Attendees
United States5970
08

Study locations

1 site
  • Flint Community
    Flint, Michigan 48502, United States
09

References and documents

Publications

  • Robles MC, Springer MV, Corches CL, Burke JF, Lin CC, Oliver A, Skolarus LE. Stroke Ready Very Brief Intervention Improves Immediate Postintervention Stroke Preparedness. Circ Cardiovasc Qual Outcomes. 2020 Dec;13(12):e006643. doi: 10.1161/CIRCOUTCOMES.120.006643. Epub 2020 Nov 26. No abstract available. PubMed 33238728 ↗
  • Skolarus LE, Sales AE, Zimmerman MA, Corches CL, Landis-Lewis Z, Robles MC, McBride AC, Rehman N, Oliver A, Islam N, Springer MV, O'Brien A, Bailey S, Morgenstern LB, Meurer WJ, Burke JF. Stroke Ready: a multi-level program that combines implementation science and community-based participatory research approaches to increase acute stroke treatment: protocol for a stepped wedge trial. Implement Sci. 2019 Mar 7;14(1):24. doi: 10.1186/s13012-019-0869-3. PubMed 30845958 ↗

Study documents

  • Protocol and statistical analysis plan · Jul 23, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03645590
Lead sponsor
University of Michigan
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD)
Responsible party
Lesli Skolarus (Associate Professor of Neurology, University of Michigan) — Principal investigator
First posted
Aug 24, 2018
Start date
Jun 20, 2018
Primary completion
Mar 31, 2021
Completion
Mar 31, 2021
Results posted
May 1, 2026
Last update
May 1, 2026

Study contacts

Lesli Skolarus, MD
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion